Long Term Debt Summary of Covalon Technologies Ltd.

Covalon Technologies Ltd.'s latest annual long term debt in 2023 was 919.08 Thousand CAD , down -41.05% from previous year.
Covalon Technologies Ltd.'s latest quarterly long term debt in 2024 Q2 was 588.3 Thousand CAD , down 0.0% from previous quarter.
Covalon Technologies Ltd. reported annual long term debt of 1.55 Million CAD in 2022, down -23.93% from previous year.
Covalon Technologies Ltd. reported annual long term debt of 2.04 Million CAD in 2021, down -23.05% from previous year.
Covalon Technologies Ltd. reported quarterly long term debt of 412.68 Thousand CAD for 2024 Q3, down 0.0% from previous quarter.
Covalon Technologies Ltd. reported quarterly long term debt of 588.3 Thousand CAD for 2024 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Covalon Technologies Ltd. (2023 - 2005)

Historical Annual Long Term Debt of Covalon Technologies Ltd. (2023 - 2005)

Year	Long Term Debt	Long Term Debt Growth
2023	919.08 Thousand CAD	-41.05%
2022	1.55 Million CAD	-23.93%
2021	2.04 Million CAD	-23.05%
2020	2.66 Million CAD	-57.69%
2019	6.29 Million CAD	0.0%
2018	- CAD	0.0%
2017	- CAD	0.0%
2016	- CAD	0.0%
2015	- CAD	-100.0%
2014	660.51 Thousand CAD	28.0%
2013	516.01 Thousand CAD	0.0%
2012	- CAD	0.0%
2011	- CAD	0.0%
2010	- CAD	0.0%
2009	- CAD	0.0%
2008	- CAD	0.0%
2007	- CAD	0.0%
2006	- CAD	0.0%
2005	- CAD	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	737.32 Thousand CAD	0.0%
2024 Q3	412.68 Thousand CAD	0.0%
2024 Q2	588.3 Thousand CAD	0.0%
2023 FY	919.08 Thousand CAD	-41.05%
2023 Q1	1.38 Million CAD	-10.87%
2023 Q2	1.23 Million CAD	-10.8%
2023 Q4	919.08 Thousand CAD	-13.45%
2023 Q3	1.06 Million CAD	-14.33%
2022 FY	1.55 Million CAD	-23.93%
2022 Q3	1.67 Million CAD	-6.57%
2022 Q1	1.9 Million CAD	-7.17%
2022 Q4	1.55 Million CAD	-6.97%
2022 Q2	1.79 Million CAD	-5.72%
2021 Q4	2.04 Million CAD	-4.78%
2021 Q1	2.45 Million CAD	-7.69%
2021 Q3	2.15 Million CAD	-6.75%
2021 FY	2.04 Million CAD	-23.05%
2021 Q2	2.3 Million CAD	-6.12%
2020 Q4	2.66 Million CAD	-7.36%
2020 Q2	3.05 Million CAD	2.41%
2020 Q3	2.87 Million CAD	-5.74%
2020 FY	2.66 Million CAD	-57.69%
2020 Q1	2.97 Million CAD	-52.68%
2019 Q2	10.21 Million CAD	11.07%
2019 Q4	6.29 Million CAD	2.48%
2019 FY	6.29 Million CAD	0.0%
2019 Q1	9.19 Million CAD	0.0%
2019 Q3	6.14 Million CAD	-39.87%
2018 Q1	- CAD	0.0%
2018 Q4	- CAD	0.0%
2018 FY	- CAD	0.0%
2018 Q2	- CAD	0.0%
2018 Q3	- CAD	0.0%
2017 Q3	- CAD	0.0%
2017 Q2	- CAD	0.0%
2017 Q4	- CAD	0.0%
2017 FY	- CAD	0.0%
2017 Q1	- CAD	0.0%
2016 Q3	- CAD	0.0%
2016 Q1	- CAD	0.0%
2016 FY	- CAD	0.0%
2016 Q4	- CAD	0.0%
2016 Q2	- CAD	0.0%
2015 Q4	- CAD	-100.0%
2015 FY	- CAD	-100.0%
2015 Q3	780.14 Thousand CAD	4.29%
2015 Q2	748.03 Thousand CAD	6.32%
2015 Q1	703.59 Thousand CAD	6.52%
2014 FY	660.51 Thousand CAD	28.0%
2014 Q1	549.32 Thousand CAD	6.45%
2014 Q3	621.48 Thousand CAD	6.42%
2014 Q2	584.01 Thousand CAD	6.32%
2014 Q4	660.51 Thousand CAD	6.28%
2013 Q4	516.01 Thousand CAD	0.0%
2013 Q2	- CAD	0.0%
2013 Q1	- CAD	0.0%
2013 FY	516.01 Thousand CAD	0.0%
2013 Q3	- CAD	0.0%
2012 Q2	- CAD	0.0%
2012 Q1	- CAD	0.0%
2012 Q3	- CAD	0.0%
2012 Q4	- CAD	0.0%
2012 FY	- CAD	0.0%
2011 Q1	- CAD	0.0%
2011 FY	- CAD	0.0%
2011 Q3	- CAD	0.0%
2011 Q4	- CAD	0.0%
2011 Q2	- CAD	0.0%
2010 Q3	- CAD	0.0%
2010 Q4	- CAD	0.0%
2010 Q1	- CAD	0.0%
2010 Q2	- CAD	0.0%
2010 FY	- CAD	0.0%
2009 Q3	- CAD	0.0%
2009 Q2	- CAD	0.0%
2009 Q4	- CAD	0.0%
2009 FY	- CAD	0.0%
2009 Q1	- CAD	0.0%
2008 Q2	- CAD	0.0%
2008 Q1	- CAD	0.0%
2008 Q4	- CAD	0.0%
2008 FY	- CAD	0.0%
2008 Q3	- CAD	0.0%
2007 FY	- CAD	0.0%
2007 Q2	- CAD	0.0%
2007 Q3	- CAD	0.0%
2007 Q4	- CAD	0.0%
2007 Q1	- CAD	0.0%
2006 Q4	- CAD	0.0%
2006 FY	- CAD	0.0%
2006 Q1	- CAD	0.0%
2006 Q2	- CAD	0.0%
2006 Q3	- CAD	0.0%
2005 Q3	- CAD	0.0%
2005 FY	- CAD	0.0%
2005 Q1	- CAD	0.0%
2005 Q4	- CAD	0.0%
2005 Q2	- CAD	0.0%

Peer Long Term Debt Comparison of Covalon Technologies Ltd.

Name	Long Term Debt	Long Term Debt Difference
Eiger BioPharmaceuticals, Inc.	- USD	-Infinity%
Nanobac Pharmaceuticals, Incorporated	- USD	-Infinity%
SQZ Biotechnologies Company	20.9 Million USD	95.604%
Evofem Biosciences, Inc.	8000.00 USD	-11388.5%
Santhera Pharmaceuticals Holding AG	1.75 Million USD	47.645%
Mesoblast Limited	100.29 Million USD	99.084%
Propanc Biopharma, Inc.	58.64 Thousand USD	-1467.273%
Genus plc	228.2 Million USD	99.597%
VioQuest Pharmaceuticals, Inc.	- USD	-Infinity%
CNBX Pharmaceuticals Inc.	- USD	-Infinity%
Marizyme, Inc.	667.12 Thousand USD	-37.766%
ContraFect Corporation	2.21 Million USD	58.413%
Nymox Pharmaceutical Corporation	- USD	-Infinity%
PsyBio Therapeutics Corp.	- USD	-Infinity%
Sienna Biopharmaceuticals, Inc.	- USD	-Infinity%
RegeneRx Biopharmaceuticals, Inc.	1.4 Million USD	34.489%
Intellipharmaceutics International Inc.	- USD	-Infinity%
AXIM Biotechnologies, Inc.	5.42 Million USD	83.063%
MultiCell Technologies, Inc.	36.43 USD	-2522765.77%
Accustem Sciences Inc.	- USD	-Infinity%
RVL Pharmaceuticals plc	55.61 Million USD	98.347%
EV Biologics, Inc.	- USD	-Infinity%
Q BioMed Inc.	- USD	-Infinity%
Emmaus Life Sciences, Inc.	2.22 Million USD	58.712%
Neon Bloom, Inc.	- USD	-Infinity%
Mosaic ImmunoEngineering Inc.	1.22 Million USD	25.178%
Biomind Labs Inc.	- USD	-Infinity%
TetraLogic Pharmaceuticals Corporation	- USD	-Infinity%
Pharming Group N.V.	166.1 Million USD	99.447%
Oncotelic Therapeutics, Inc.	1.89 Million USD	51.588%
Skye Bioscience, Inc.	171.23 Thousand USD	-436.752%
Therapeutic Solutions International, Inc.	5512.00 USD	-16574.165%
THC Farmaceuticals, Inc.	- USD	-Infinity%
Arch Therapeutics, Inc.	- USD	-Infinity%
IMV Inc.	27.39 Million USD	96.646%
Acro Biomedical Co., Ltd.	- USD	-Infinity%
Curative Biotechnology, Inc.	- USD	-Infinity%
GB Sciences, Inc.	322 Thousand USD	-185.429%
Alpha Cognition Inc.	- USD	-Infinity%
HST Global, Inc.	- USD	-Infinity%
CSL Limited	11.23 Billion USD	99.992%
Halberd Corporation	150 Thousand USD	-512.72%
Enzolytics Inc.	- USD	-Infinity%
Resverlogix Corp.	- USD	-Infinity%
Affymax, Inc.	- USD	-Infinity%
SYBLEU INC	300 Thousand USD	-206.36%
Nuo Therapeutics, Inc.	164.2 Thousand USD	-459.715%
argenx SE	15.35 Million USD	94.014%
MetaStat, Inc.	- USD	-Infinity%
Northwest Biotherapeutics, Inc.	20.31 Million USD	95.475%
Enzon Pharmaceuticals, Inc.	- USD	-Infinity%
Arno Therapeutics, Inc.	- USD	-Infinity%
RespireRx Pharmaceuticals Inc.	- USD	-Infinity%
GeneThera, Inc.	- USD	-Infinity%
Inhibitor Therapeutics, Inc.	- USD	-Infinity%
AVAX Technologies, Inc.	- USD	-Infinity%
Zenith Capital Corp.	4456.00 USD	-20525.673%
Genscript Biotech Corporation	287.12 Million USD	99.68%
Ember Therapeutics, Inc.	- USD	-Infinity%
Anthera Pharmaceuticals, Inc.	- USD	-Infinity%
Sigyn Therapeutics, Inc.	126.3 Thousand USD	-627.684%
WPD Pharmaceuticals Inc.	229.29 Thousand USD	-300.836%
American Oriental Bioengineering, Inc.	554.59 Thousand USD	-65.722%
Provectus Biopharmaceuticals, Inc.	25.29 Thousand USD	-3532.871%
Adynxx, Inc.	- USD	-Infinity%
Helix BioMedix, Inc.	- USD	-Infinity%
GlobeStar Therapeutics Corporation	- USD	-Infinity%
VitaSpring Biomedical Co. Ltd.	- USD	-Infinity%
Capstone Therapeutics Corp.	8.26 Million USD	88.879%
Cotinga Pharmaceuticals Inc.	- USD	-Infinity%
BioStem Technologies, Inc.	265.63 Thousand USD	-245.994%
ONE Bio Corp.	592.19 Thousand USD	-55.198%
Reve Technologies, Inc.	1064.00 USD	-86279.699%
Burzynski Research Institute, Inc.	- USD	-Infinity%
Wesana Health Holdings Inc.	- USD	-Infinity%
Agentix Corp.	- USD	-Infinity%
LadRx Corporation	- USD	-Infinity%
Cell Source, Inc.	- USD	-Infinity%
ProtoKinetix, Incorporated	- USD	-Infinity%
Regen BioPharma, Inc.	149.61 Thousand USD	-514.301%
Regen BioPharma, Inc.	149.61 Thousand USD	-514.301%
NovAccess Global Inc.	- USD	-Infinity%
Endonovo Therapeutics, Inc.	- USD	-Infinity%
Itoco Inc.	- USD	-Infinity%
Rasna Therapeutics, Inc.	- USD	-Infinity%
Pathfinder Cell Therapy, Inc.	- USD	-Infinity%
Kadimastem Ltd	229.69 Thousand USD	-300.138%
Oncology Pharma Inc.	- USD	-Infinity%
Institute of Biomedical Research Corp.	- USD	-Infinity%
CytoDyn Inc.	141 Thousand USD	-551.83%
Claritas Pharmaceuticals, Inc.	- USD	-Infinity%
NDT Pharmaceuticals Inc.	- USD	-Infinity%
Mobile Lads Corp.	- USD	-Infinity%
NanoSphere Health Sciences Inc.	- USD	-Infinity%
Qrons Inc.	80 Thousand USD	-1048.85%
Alseres Pharmaceuticals, Inc.	7.81 Million USD	88.247%
Advanced Proteome Therapeutics Corporation	- USD	-Infinity%
Nascent Biotech, Inc.	- USD	-Infinity%
Rebus Holdings, Inc.	- USD	-Infinity%
ImmunoCellular Therapeutics, Ltd.	369.04 Thousand USD	-149.04%
International Stem Cell Corporation	445 Thousand USD	-106.535%
Bioxytran, Inc.	- USD	-Infinity%
GlobeImmune, Inc.	- USD	-Infinity%
Predictive Technology Group, Inc.	- USD	-Infinity%
ProText Mobility, Inc.	- USD	-Infinity%
Cardax, Inc.	- USD	-Infinity%
VG Life Sciences Inc.	- USD	-Infinity%
Kaleido Biosciences, Inc.	- USD	-Infinity%
Advaxis, Inc.	8.15 Million USD	88.723%
Adhera Therapeutics, Inc.	- USD	-Infinity%
RenovaCare, Inc.	- USD	-Infinity%
Regnum Corp.	- USD	-Infinity%
Innovation Pharmaceuticals Inc.	457 Thousand USD	-101.112%
Neutra Corp.	- USD	-Infinity%
Windtree Therapeutics, Inc.	1.16 Million USD	20.837%
PureTech Health plc	18.25 Million USD	94.964%
Coeptis Therapeutics, Inc.	150 Thousand USD	-512.72%
IXICO plc	275 Thousand USD	-234.211%
IntelGenx Technologies Corp.	11.83 Million USD	92.237%
Gelesis Holdings, Inc.	26.3 Million USD	96.507%
CSL Limited	11.23 Billion USD	99.992%
Cellectis S.A.	36.21 Million USD	97.462%

Global Stocks Search

Covalon Technologies Ltd. (CVALF)

Long Term Debt Summary of Covalon Technologies Ltd.

Annual Long Term Debt Chart of Covalon Technologies Ltd. (2023 - 2005)

Historical Annual Long Term Debt of Covalon Technologies Ltd. (2023 - 2005)

Peer Long Term Debt Comparison of Covalon Technologies Ltd.